Authors: Martin, R Barron, JJ Zacker, C

Citation: R. Martin et al., Irritable bowel syndrome: Toward a cost-effective management approach, AM J M CARE, 7(8), 2001, pp. S268-S275

Authors: Fahlman, C Stuart, B Zacker, C

Citation: C. Fahlman et al., Community pharmacist knowledge and behavior in collecting drug copayments from Medicaid recipients, AM J HEAL S, 58(5), 2001, pp. 389-395

Authors: Castel, LD Bajwa, K Markle, JP Timbie, JW Zacker, C Schulman, KA

Citation: Ld. Castel et al., A microcosting analysis of zoledronic acid and pamidronate therapy in patients with metastatic bone disease, SUPP CARE C, 9(7), 2001, pp. 545-551

Authors: Beusterien, KM Hill, MC Ackerman, SJ Zacker, C

Citation: Km. Beusterien et al., The impact of pamidronate on inpatient and outpatient services among metastatic breast cancer patients, SUPP CARE C, 9(3), 2001, pp. 169-176

Authors: Zaman, A Arnold, RJG Pettit, KG Kaniecki, DJ Benner, K Zacker, C DiCesare, J Helfand, M

Citation: A. Zaman et al., Cost of treating an episode of variceal bleeding in a VA setting, AM J GASTRO, 95(5), 2000, pp. 1323-1330

Authors: Stuart, B Zacker, C

Citation: B. Stuart et C. Zacker, Who bears the burden of Medicaid drug copayment policies?, HEAL AFFAIR, 18(2), 1999, pp. 201-212